Zobrazeno 1 - 10
of 233
pro vyhledávání: '"Brian C Baumann"'
Autor:
Sana S. Dastgheyb, MD, PhD, Alexandra D. Dreyfuss, MD, Michael J. LaRiviere, MD, Jahan J. Mohiuddin, MD, Brian C. Baumann, MD, Jacob Shabason, MD, Robert A. Lustig, MD, Jay F. Dorsey, MD, PhD, Alexander Lin, MD, Sean M. Grady, MD, Bert W. O'Malley, MD, John Y.K. Lee, MD, Jason G. Newman, MD, James M. Schuster, MD, Michelle Alonso-Basanta, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 9, Iss 5, Pp 101456- (2024)
Purpose: The purpose of this study was to evaluate the feasibility and safety of dose-escalated proton beam therapy for treating chordomas and chondrosarcomas of the skull base and spine. Methods: A prospective cohort of 54 patients (42 with chordoma
Externí odkaz:
https://doaj.org/article/6c2512a62ba94b05937e5324b2822bd6
Autor:
Michael Waters, Alex Price, Eric Laugeman, Lauren Henke, Geoff Hugo, Hayley Stowe, Neal Andruska, Randall Brenneman, Yao Hao, Olga Green, Clifford Robinson, Hiram Gay, Jeff Michalski, Brian C. Baumann
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 44, Iss , Pp 100693- (2024)
Introduction: Stereotactic body radiation therapy (SBRT) is an emerging treatment modality for clinically localized prostate cancer (PCa). Online daily adaptive radiotherapy (ART) could potentially improve the therapeutic ratio of prostate SBRT by ac
Externí odkaz:
https://doaj.org/article/a15233a6249f42a88839a1b239eb0956
Autor:
Alex T. Price, Joshua P. Schiff, Eric Laugeman, Borna Maraghechi, Matthew Schmidt, Tong Zhu, Francisco Reynoso, Yao Hao, Taeho Kim, Eric Morris, Xiaodong Zhao, Geoffrey D. Hugo, Gregory Vlacich, Carl J. DeSelm, Pamela P. Samson, Brian C. Baumann, Shahed N. Badiyan, Clifford G. Robinson, Hyun Kim, Lauren E. Henke
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 42, Iss , Pp 100661- (2023)
Introduction: Our institution was the first in the world to clinically implement MR-guided adaptive radiotherapy (MRgART) in 2014. In 2021, we installed a CT-guided adaptive radiotherapy (CTgART) unit, becoming one of the first clinics in the world t
Externí odkaz:
https://doaj.org/article/c939318c42664610b1fd13a03ab0767c
Autor:
Pradeep S. Chauhan, Alexander Shiang, Irfan Alahi, R. Taylor Sundby, Wenjia Feng, Bilge Gungoren, Cayce Nawaf, Kevin Chen, Ramandeep K. Babbra, Peter K. Harris, Faridi Qaium, Casey Hatscher, Anna Antiporda, Lindsey Brunt, Lindsey R. Mayer, Jack F. Shern, Brian C. Baumann, Eric H. Kim, Melissa A. Reimers, Zachary L. Smith, Aadel A. Chaudhuri
Publikováno v:
npj Precision Oncology, Vol 7, Iss 1, Pp 1-6 (2023)
Abstract Circulating tumor DNA (ctDNA) sensitivity remains subpar for molecular residual disease (MRD) detection in bladder cancer patients. To remedy this problem, we focused on the biofluid most proximal to the disease, urine, and analyzed urine tu
Externí odkaz:
https://doaj.org/article/6c08dcfd52c5447997c27e3e554c3cca
Autor:
Benjamin W. Fischer-Valuck, Brian C. Baumann, Simon A. Brown, Christopher P. Filson, Aaron Weiss, Ryan Mueller, Yuan Liu, Randall J. Brenneman, Martin Sanda, Jeff M. Michalski, Hiram A. Gay, Yuan James Rao, John G. Pattaras, Ashesh B. Jani, Bruce Hershatter, Sagar A. Patel
Publikováno v:
European Urology Open Science, Vol 37, Iss , Pp 80-89 (2022)
Background: Elderly patients diagnosed with high-risk prostate cancer (PCa) present a therapeutic dilemma of balancing treatment of a potentially lethal malignancy with overtreatment of a cancer that may not threaten life expectancy. Objective: To in
Externí odkaz:
https://doaj.org/article/bed16021cbda402da7800649e253f019
Autor:
Amit Roy, Randall J. Brenneman, Jacob Hogan, Justin M. Barnes, Yi Huang, Robert Morris, Sreekrishna Goddu, Michael Altman, Jose Garcia-Ramirez, Harold Li, Jacqueline E. Zoberi, Arnold Bullock, Eric Kim, Zachary Smith, Robert Figenshau, Gerald L. Andriole, Brian C. Baumann, Jeff M. Michalski, Hiram A. Gay
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 29, Iss , Pp 47-53 (2021)
Background: We present the first report comparing early toxicity outcomes with high-dose rate brachytherapy (HDR-BT) boost upfront versus intensity modulated RT (IMRT) upfront combined with androgen deprivation therapy (ADT) as definitive management
Externí odkaz:
https://doaj.org/article/7af1a850b3314a018b5f641b2fc46e0e
Publikováno v:
Journal of the Egyptian National Cancer Institute, Vol 32, Iss 1, Pp 1-10 (2020)
Abstract Background Urinary schistosomiasis and its severe complications, mainly bladder cancer, are scarce in non-endemic areas. The deficiency in knowledge and clinical experience of schistosomiasis may lead to inadequate management. Highlighting t
Externí odkaz:
https://doaj.org/article/1ee3f33099bd4952871aa5e66aeb9a25
Autor:
Pradeep S Chauhan, Kevin Chen, Ramandeep K Babbra, Wenjia Feng, Nadja Pejovic, Armaan Nallicheri, Peter K Harris, Katherine Dienstbach, Andrew Atkocius, Lenon Maguire, Faridi Qaium, Jeffrey J Szymanski, Brian C Baumann, Li Ding, Dengfeng Cao, Melissa A Reimers, Eric H Kim, Zachary L Smith, Vivek K Arora, Aadel A Chaudhuri
Publikováno v:
PLoS Medicine, Vol 18, Iss 8, p e1003732 (2021)
BackgroundThe standard of care treatment for muscle-invasive bladder cancer (MIBC) is radical cystectomy, which is typically preceded by neoadjuvant chemotherapy. However, the inability to assess minimal residual disease (MRD) noninvasively limits ou
Externí odkaz:
https://doaj.org/article/68ac59a93c0e4cf082db6dfecd686ee0
Autor:
Benjamin W. Fischer‐Valuck, Jeff M. Michalski, Nandita Mitra, John P. Christodouleas, Todd A. DeWees, Eric Kim, Zachary L. Smith, Gerald L. Andriole, Vivek Arora, Arnold Bullock, Ruben Carmona, Robert S. Figenshau, Robert L. Grubb, Thomas J. Guzzo, Eric M. Knoche, S. Bruce Malkowicz, Ronac Mamtani, Russell K. Pachynski, Bruce J. Roth, Mohamed S. Zaghloul, Hiram A. Gay, Brian C. Baumann
Publikováno v:
Cancer Medicine, Vol 8, Iss 8, Pp 3698-3709 (2019)
Abstract Background Local‐regional failure (LF) for locally advanced bladder cancer (LABC) after radical cystectomy (RC) is common even with chemotherapy and is associated with high morbidity/mortality. Postoperative radiotherapy (PORT) can reduce
Externí odkaz:
https://doaj.org/article/7476407db02e464298e90497e8635fe0
Autor:
Benjamin W. Fischer-Valuck, Jeff M. Michalski, Jessika A. Contreras, Randall Brenneman, John P. Christodouleas, Christopher D. Abraham, Eric H. Kim, Vivek K. Arora, Arnold D. Bullock, Ruben Carmona, Robert S. Figenshau, Robert Grubb, III, Eric M. Knoche, Russell K. Pachynski, Joel Picus, Bruce J. Roth, Paul Sargos, Gerald L. Andriole, Hiram A. Gay, Brian C. Baumann
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 15, Iss , Pp 38-41 (2019)
Introduction: Squamous cell carcinoma (SqCC) is the second most common histology of primary bladder cancer, but still very limited information is known about its treatment outcomes. Most bladder cancer trials have excluded SqCC, and the current treat
Externí odkaz:
https://doaj.org/article/d651c57419134a0cb6af5d407b8deb97